Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
Morning Overview on MSN
The Ozempic breast-cancer benefit held even after researchers accounted for weight loss
Millions of women taking semaglutide or similar GLP-1 receptor agonists for diabetes and obesity now have a new data point to ...
In some countries, breast reduction surgery is now becoming more popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results